Evaluation of Different Etiologies of Obscure Ascites
Sponsor
Assiut University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03205748
Collaborator
(none)
50
1
15
3.3
Study Details
Study Description
Brief Summary
Ascites refers to fluid that accumulates within the peritoneal cavity. Although ascites is most commonly observed in patients with cirrhosis and resulting portal hypertension (approximately 85% of cases), 7% to 10% of patients with ascites develop secondary to a malignancy
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Different Etiologies of Obscure Ascites: Clinical, Laboratory, and Laparoscopic Study.
Actual Study Start Date
:
Aug 1, 2017
Anticipated Primary Completion Date
:
Aug 1, 2018
Anticipated Study Completion Date
:
Nov 1, 2018
Outcome Measures
Primary Outcome Measures
- The percentage of patients with malignant ascites [1 month]
according to laboratory and clinical criteria
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
-
Patients with ascites
-
serum ascites albumin gradient >1.1.
Exclusion Criteria:
-
ascitic fluid serum ascites albumin gradient <1.1.
-
Haemorrgaic ascites;
-
chylous ascites
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Assiut Faculty of Medicine | Assiut | Egypt |
Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ahmed Mohamed Abbas,
Principal investigator,
Assiut University
ClinicalTrials.gov Identifier:
NCT03205748
Other Study ID Numbers:
- OA
First Posted:
Jul 2, 2017
Last Update Posted:
Nov 29, 2017
Last Verified:
Nov 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: